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Abstract
Background: Several research trials have analyzed the impact of prematurity on the prevalence of hypertension (HT). However,
prospective long-term studies are lacking.
Objectives: The aim of this study was to evaluate the prevalence of HT at the age of 7 and 11 years in a regional cohort of preterm
infants with a birth weight of ≤ 1000 g.
Patients and Methods: This study included 67 children with a birth weight of ≤ 1000 g who were born in Malopolska between
September 2002 and August 2004. The control group consisted of 38 children born at term, matched for age. Each child underwent
24-h ambulatory blood pressure measurement (ABPM) twice, once at the age of 7 and again at 11 years. The presence of HT was
estimated according to the mean arterial pressure (MAP) and a number of individual measurements.
Results: At aged 7 years, preterm infants had a significantly higher incidence of HT, defined on the basis of MAP (15% vs. 0%; P <
0.02) and on the percent of individual measurements (56% vs. 33%, P < 0.036). After taking into account the group of patients who
received anti-HT treatment after the first part of the study, the incidence of HT at the age of 11 years based on MAP was 19% vs. 10%.
Based on the individual measurements, it was 36.5% in the preterm infants vs. 24% in the control group. The differences were not
statistically significant. At both time points, the preterm group had a higher mean heart rate (HR) than the control group.
Conclusions: Children born prematurely are predisposed to HT in later life, in addition to the persistence of an increased HR.
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1. Background
Preterm births account for 5.2 - 10.4% of live births in
European countries (1). In the U.S., the percentage is even
higher and reaches 12.5% (2). Mortality associated with dy-
namic complications that occur in the first few weeks of
a preterm infant’s life has markedly decreased in the last
decade (3, 4). Despite this, preterm births continue to pose
a challenge in perinatal healthcare, and they remain the
major cause of death in the first years of a child’s life (5, 6).
The most severe complications of prematurity are res-
piratory distress syndrome, intraventricular hemorrhage,
patent ductus arteriosus, necrotizing enterocolitis, and
sepsis. Prematurity also influences health issues in later
life, with the complications including bronchopulmonary
dysplasia, retinopathy (7, 8), learning difficulties, and be-
havioral disorders (9). Recently, several multicenter re-
search trials have analyzed the impact of prematurity on
health problems of children and adolescences. This re-
search demonstrated that prematurity was an indepen-
dent risk factor for obesity, eclampsia, type 2 diabetes, and
even breast cancer (10, 11). Many studies have also proven
that hypertension (HT) occurs more often in ex-preterm in-
fants. In a study of children with appropriate birth weight,
significantly higher pressure values were measured al-
ready after the first month of preterms’ life (12). Further-
more, birth parameters determine higher blood pressure
(BP) values stronger than any anthropometric measure-
ment (13).
Prospective studies are lacking on the health problems
of ex-preterms throughout childhood and adulthood. This
issue is more important then ever today, with increasing
numbers of ex-preterms entering adulthood every year
with many complications.
HT is one of the major causes of untimely death in the
world (14). Pediatric HT is also a significant problem, as
it frequently persists in adulthood and increases cardio-
vascular risks in later life (15-17). HT is present in 30 - 45%
of adults, and its incidence increases with age (14). It was
shown that only in a small percentage of HT patients, ele-
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vated BP was an isolated problem. Many patients with HT
were shown to have multiple cardiovascular risk factors
and to have target organ damage. The most frequent types
of target organ damage due to HT are left ventricular hy-
pertrophy, intima-media thickening, and kidney damage
(18). In children and adolescents, the most common HT-
related organ damage is left ventricular hypertrophy, with
a reported prevalence in children of 14 - 42%. Complica-
tions of elevated BP are often observed at the time of its di-
agnosis in children and affect subsequent health (19, 20).
Therefore, HT in the first years of life is not only a pediatric
problem.
We previously published the results of 24-h BP mea-
surements of ex-preterms acquired at the age of 7 years. In
this paper, we discuss the results collected at the age of 11
years. We selected the age of 6 - 7 years as the time of the
first follow-up on the basis that this is when children in
Poland start school. The second follow-up (age 11 years) was
selected because it is just before maturation. Furthermore,
in the second decade of life, the frequency of primary HT in-
creases, which could influence outcomes. In our opinion,
a 4-year-long follow-up is sufficient to observe changes in
BP profiles.
2. Objectives
This was a prospective, 4-year-long observation study
of the BP profiles of a large cohort of preterm infants with
extremely low birth weights (ELBWs) and those of full-term
infants. The hypothesis was that preterms with an ELBW
(i.e., ≤ 1000 g) would have a greater risk of HT compared
with that of full-term infants. Moreover, we speculated that
proper management of early-diagnosed HT would have a
beneficial effect and decrease the risk of severe HT (SHT) in
later life.
3. Materials andMethods
A cross-sectional observational study was conducted
in the outpatient pediatric department of the Polish-
American children’s hospital, Krakow, Poland between 30
December 2013 and 30 April 2015. The study cohort con-
sisted of ELBW survivors recruited at birth and full-term,
control participants enrolled when both groups were 6 - 7
years old. From 1 September 2002 to 31 August 2004, 169
newborns with a birth weight of < 1000 g were born alive
in the southeast region (Malopolska) of Poland. All the chil-
dren were hospitalized in three tertiary care neonatal in-
tensive care units (NICU) in southeast Poland. Neonatal
data were recorded daily during their stays in the NICUs in
a prospective manner and stored in computer databases.
Ninety-one survivors were discharged from the NICUs and
followed longitudinally. Those patients were subsequently
invited to participate in the follow-up assessment at 6 - 7
years and in the present follow-up study. The inclusion and
exclusion criteria are presented in Box 1. Detailed results
of the follow-up performed at 6 - 7 years have already been
published (21). The control group included age-matched
children from one general practice office. The ethical com-
mittee for clinical investigations of Collegium Medicum,
Jagiellonian University approved the study. All the parents
signed informed consent prior to the study procedures.
Box 1. Eligibility Criteria for the Study Group
Criteria
Inclusion criteria
Birth weight ≤ 1000 g
Place of birth - Malopolska region
Exclusion criteria
Lack of parental consent
Chromosomal aberrations Multiple congenital malformations
3.1. Study Size Calculation
The study size was calculated using PS Power and Sam-
ple Size Calculations, version 3.0 (January 2009). Previous
data indicated that systolic BP (SBP) and diastolic BP (DBP)
were normally distributed, with a standard deviation (SD)
of 10 mmHg (22). A difference in systolic and diastolic pres-
sure lower than 6 mmHg is (in our opinion) clinically in-
significant. We calculated that at least 60 experimental
subjects and 30 control subjects were needed to reject the
null hypothesis that the population means of the experi-
mental and control groups were equal, with a probability
(power) of 0.8. Our study allows detecting the lowest value
that is relevant in clinical practice. The type I error prob-
ability associated with the test of the null hypothesis was
0.05.
3.2. Follow-Up at Age 10 - 11 Years
For all children, the parents of the child completed
a questionnaire about the child’s demographic data and
health status. All the children underwent a physical exami-
nation, in addition to anthropometric measurements and
24-h BP monitoring.
3.3. Anthropometric Measurements
Using a stadiometer (SECA 214, Germany), body height
was measured to an accuracy of 1 mm while the patient
stood in an upright position, with his/her head set to the
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ocular-ear position. Body mass was measured to an accu-
racy of 10 g, using a calibrated scales (Lublin, Poland). For
each patient, the SD of height and weight was calculated to
two decimal places.
3.4. Ambulatory BP Measurement (ABPM)
The Spacelabs Healthcare device, model 92017, with a
properly matched pediatric cuff was used for 24-h ABPM.
The device was programmed to obtain BP readings every
20 minutes during daytime and every 30 minutes during
nighttime. Recordings with at least 80% validity were in-
cluded in the analysis. Licensed ABPM software was used
to calculate the following parameters: mean SBP, mean
DBP, mean arterial pressure (MAP), and mean heart rate
(HR). Each parameter was calculated for the daytime pe-
riod, nighttime period, and 24-h period. The data obtained
were converted to SD scores (z-scores). The daytime and
nighttime periods in the first ABPM were based on those ac-
cepted in the literature as time slots, which for the majority
of children are the time of activity (8.00 - 22.00 h) and the
rest of the night (0.00 - 6.00 h). At the second visit, daytime
and nighttime periods were defined on the basis of a diary
completed by the child’s parents. This approach was used
due to the presence of huge differences in the sleep profiles
of the children. Then, for each child, the 95th percentiles
of SBP and DBP were found on the basis of proper charts
(12). Nocturnal dipping was calculated as the percentage of
nighttime decreases in MAP. Normal dipping was defined
as a decline of ≥ 10% (23).
3.5. Outcome Variables
The primary outcomes were HT and SHT (Table 1).
Two definitions of HT were used. The first definition
was based on MAP. HT was diagnosed if the MAP value was
equal to or higher than the 95th percentile for height and
gender. The second definition utilized single BP measure-
ments: the BP load. HT was confirmed when more than
25% of the measurements were in the≥ 95th percentile for
height, gender, and age (24). Due to a lack of data necessary
to analyze the MAP in children with a height below 120 cm,
in children measuring between 110 and 120 cm, the stan-
dard for 120 cm was used. Due to exceptionally low heights,
the presence of HT based on MAP was not evaluated in two
children in the 7th year of life.
The presence of SHT was evaluated in children with
confirmed HT. STH poses a direct risk of target organ dam-
age. SHT was diagnosed when SBP was ≥ 95 pc for height
and gender, and the percent of SBP single measurements in
ABPM ≥ 95 pc for height, gender and age was ≥ 50% (25).
The secondary outcomes were as follows: 24-h, day-
time, and nighttime SBP, DBP, MAP, HR, and nighttime dip-
ping. All data were analyzed as absolute values and z-
scores.
The statistical analysis was performed with the use of
Statistica 10.0 software. Qualitative values were compared
by Fisher’s exact test. To test for differences in continu-
ous variables between the groups, a Student’s t-test and the
Mann-Whitney U test were used. Differences were consid-
ered statistically significant at a probability (type I error)
of alpha ≤ 0.05.
4. Results
4.1. Population
The study group comprised 67 children born prema-
turely (mean gestational age of 27 ± 2.27 weeks) with
ELBWs (mean birth weight of 850 ± 128 g). The mean age
at the time of the measurements was 6.58±0.37 years and
10.99 ± 0.34 years. The control group consisted of 38 chil-
dren (95% of the available cohort) born full-term (mean
gestational age of 39.8 ± 1.42 weeks), with a mean birth
weight of 3571 ± 538 g. The mean age of the controls was
6.99 ± 0.88 years and 10.61 ± 0.85 years. The characteris-
tics of the ELBW group and control group are presented in
Table 2.
Children born prematurely were significantly shorter
than full-term children. The mean height difference in the
7th year of life in the preterm vs. full-term group was 1 SD (z-
score: - 0.89 vs. 0.18, P < 0.01), and it remained at the same
level 4 years later (z-score: - 1.09 vs. 0.21, P < 0.01). Moreover,
the preterms’ weight was also significantly lower than that
of the controls (7 years: z-score -0.89 vs. 0.2, P < 0.01; 11
years: z-score -1.3 vs. 0.12, P < 0.01).
4.2. Prevalence of HT
In the 7th year of life, the presence of HT based on MAP
was significantly higher in the ex-preterm children. HT
based on MAP was diagnosed in eight children, whereas
none of the children in the control group were diagnosed
with HT (15% vs. 0%; P < 0.02). Thirty-two ex-preterms and
12 controls were diagnosed with HT based on BP measure-
ments alone (56% vs. 33%; P < 0.036). In the 11th year of life,
the difference between these two groups was statistically
insignificant (HT based on MAP: 15% vs. 10%, HT based on BP
measurements alone: 30.7% vs. 24%). After taking into ac-
count the children who had started treatment of HT after
the first follow-up visit, the incidence of HT based on MAP
was 19% vs. 10%, and the incidence of HT on the basis of in-
dividual measurements was 36.5% vs. 24%. The differences
were not statistically significant.
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Table 1. Definitions of the Primary Outcomes Based on the Results of 24-H ABPM
Diagnosis of HT
HT based onMAP MAP in the ≥ 95th percentile for gender and height
HT based on single BPmeasurements More than 25% of single measurements in the ≥ 95th percentile for age, gender, and height
SHT Mean SBP in the ≥ 95th percentile for gender and height and Less than or 50% of single measurements in the ≥ 95th
percentile for age, gender, and height
Abbreviations: ABPM, ambulatory blood pressure measurement; BP, blood pressure; HT, hypertension; MAP, mean arterial pressure; SHT, severe hypertension.
Table 2. Comparison of Selected Data Between ELBW Children and the Control
Group
Study Group Control Group P Value
Birth parameters
Female/male 44/23 19/23 0.15
Birth weight ( g) 850 ± 128 3571 ± 538 < 0.001
Gestational age (wk) 27 ± 2.27 39.8 ± 1.42 < 0.001
Neonatal period
interventions
Mechanical
ventilation (%)
91 0 < 0.001
Surfactant
administration (%)
73 0 < 0.001
PDA ligation (%) 27 0 < 0.001
First follow-up
Height (cm) 115.5 ± 6.7 124.9 ± 7.4 < 0.001
Height (z-score) -0,89 0,18 < 0.001
Weight (kg) 19.5 ± 3.9 25.2 ± 5.3 < 0.001
Weight (z-score) -0.9 0.2 < 0.001
Second follow-up
Height (cm) 142 ± 7 145 ± 9 0.09
Height (z-score) - 1.09 0.21 < 0.001
Weight (kg) 34 ± 8 39±8 0.017
Weight (z-score) - 1.32 0.12 < 0.001
Abbreviation: ELBW, extremely low birth weight.
4.3. SHT
Five of eight hypertensive preterms suffered from SHT
in the 7th year of life. In the 11th year of life, SHT was di-
agnosed in four patients in the ex-preterm group and in
two controls. One child with SHT did not attend the sec-
ond follow-up visit. In three children who had SHT in the
7th year of life, BP values decreased as a result of treatment
below the level thought to pose a direct risk of target organ
damage.
4.4. BP Values
In the 7th year of life, the ex-preterms had significantly
higher 24-h, daytime, and nighttime MAP z-scores than the
controls. In the 11th year of life, the difference remained
only in daytime MAP z-scores. In both the 7th and 11th
years of life, there were no statistically significant differ-
ences in absolute values of SBP, DBO, or MAP between the
ex-preterms and controls. The observed BP values are pre-
sented in Table 3.
4.5. BP Profiles (24 h)
The children with ELBWs had significantly higher
nighttime MAP (1.15 vs. 0.2 SDS; P = 0.02). However, both in
the 7th and 11th years of life, there were no significant dif-
ferences in the drop in mean nocturnal MAP (7th year: 12.9%
vs. 14.8%, P = 0.28; 11th year: 13.8 vs. 13.4%; P = 0.74). The per-
centage of children without proper (minimum 10%) noc-
turnal MAP dipping was 22.8% in the group of children
born prematurely and 19.4% in the control group. In the
11th year of life, this percentage was 22% in the first and 17%
in the second group.
4.6. HR Measurement
In both measurements, the ELBW children had a sig-
nificantly higher HR in comparison to that of the full-term
children (7th year of life: 93 vs. 87/min, P < 0.001; 11th year
of life: 87 vs. 83/min, P = 0.039). Moreover, in the 7th year of
life, there was a significant difference in the daytime and
nighttime HRs between the ex-preterm group and the con-
trols (daytime HR: 99 vs. 94/min, P = 0.01, nighttime HR: 86
vs. 79/min, P < 0.001).
5. Discussion
Prematurity and low birth weight are strong risk fac-
tors for HT in the first decade of life. In studies evaluating
BP in children younger than 12 years old, the prevalence of
HT ranged from 10 to 25% (26, 27). A higher frequency of HT
was observed in young adults born with a very low birth
(25). The present study revealed a significant difference in
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Table 3. Comparison of 24-H Abpms Between the ELBW Group and Controls
7th Year of Life 11th Year of Life
Study Group Control Group P Value Study Group Control Group P Value
MAP 24 h (mmHg) 79 ± 6 77 ± 5 0.12 82 ± 4 82 ± 5 0.89
MAP day (mmHg) 83 ± 6 82 ± 5 0.46 84 ± 5 83 ± 5 0.79
MAP night (mmHg) 72 ± 6 70 ± 4 0.23 72 ± 4 73 ± 6 0.62
SBP 24 h (mmHg) 104 ± 7 103 ± 6 0.5 109 ± 7 108 ± 8 0.84
SBP day (mmHg) 106 ± 7 106 ± 6 0.97 111 ± 7 110 ± 8 0.77
SBP night (mmHg) 100 ± 7 98 ± 6 0.26 99 ± 7 99 ± 8 0.9
DBP 24 h (mmHg) 65 ± 5 64 ± 5 0.56 67 ± 4 67 ± 5 0.69
DBP day (mmHg) 68 ± 5 69 ± 5 0.66 69 ± 5 69 ± 5 0.94
DBP night (mmHg) 60 ± 5 59 ± 5 0.53 55 ± 5 57 ± 6 0.4
MAP 24 h (z-score) 0.5 ± 1.1 -0.3 ± 0.78 < 0.01 0.26 ± 0.6 0.19 ± 0.7 0.61
MAP day (z-score) -0.36 ± 0.9 -0.7 ± 0.73 0.05 -0.01 ± 0.78 -0.34 ± 0.73 0.04
MAP night (z-score) 1.15 ± 0.84 0.2 ± 0.72 0.02 0.58 ± 0.71 0.23 ± 0.91 0.0508
SBP 24 h (z-score) -0.13 ± 1.14 -0.45 ± 0.86 0.15 -0.08 ± 1.02 -0.31 ± 1.2 0.34
DBP 24 h (z-score) -0.08 ± 1.07 -0.4 ± 0.96 0.14 0.06 ± 0.82 0.01 ± 0.89 0.78
Nocturnal MAP dipping (%) 15.9 ± 17.4 14.8 ± 5 0.28 13.8 ± 6 13.4 ± 4 0.74
Abbreviations: ABPM, ambulatory blood pressure measurement; DBP, diastolic blood pressure; ELBW, extremely low birth weight; MAP, mean arterial pressure; SBP,
systolic blood pressure.
the frequency of HT between prematurely born children
and controls in the 7th year of life (eight patients vs. zero
controls). In the 11th year of life, there were eight diag-
noses of HT in the ex-preterm group compared to three di-
agnoses in the control group. After taking into account
the children who had started pharmacological treatment
for HT after the first follow-up visit, the incidence of HT
was 10 versus three cases. There were two new diagnoses
at the second follow-up visit in the ex-preterm group and
three in the control group. The frequency of HT in the con-
trol group was in accordance with previously published
data, which showed that the prevalence of HT in previously
healthy children reached 4% in the first and 12% in the sec-
ond decades of life (28).
As mentioned before, complications of elevated BP are
often observed at the time of its diagnosis in children (19,
20). Performing ABPM at a young age makes it possible to
identify children with SHT, who have a high risk of end-
organ damage (29). In the present study, five of eight 7-year-
old patients in whom HT was diagnosed already had SHT. It
is worth noting that in 75% of these SHT cases, by appropri-
ate treatment, we were able to decrease BP values below the
level that presents a direct risk of target organ damage.
Due to the consequences of HT in later life and
the possibility of prevention, it is necessary to conduct
widespread screening and detect high BP among children.
Especially insightful attention is required in patients from
a group of HT risk because early diagnosis with adequate
treatment can avoid complications and reduce cardiovas-
cular risks in subsequent years.
In recently published studies, besides HT diagnoses,
absolute values of SBP and DBP were analyzed. Many of
those studies reported that the main concern in prema-
turely born children was elevated SBP. Much more studies
of former preterm newborns detected significantly higher
SBP (19, 22, 25, 26, 30-33), then elevated DBP values (25, 31, 33,
34). A few studies reported significantly higher MAP in ex-
preterm infants compared to controls (31-33). The present
study confirmed the presence of higher values of MAP in
children who had a low birth weight when they reached
the 7th year of life. In the 11th year of life, this difference
was not statistically significant. However, we have to take
into account the fact that the children in the study group
were significantly shorter than those in the control group,
and this difference reaches a value of 1 SD.
Another parameter that must be considered in chil-
dren born prematurely is nighttime BP. Research has
demonstrated that a lack of nocturnal MAP dipping is a risk
factor for cardiovascular events (35). Moreover, increased
nighttime BP was shown to predict the occurrence of mi-
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croalbuminuria in children with diabetes (36). Bayrakci et
al. demonstrated a reverse correlation between high night-
time z-scores for SBP and birth weight in a group of chil-
dren aged 5 - 17 years (26). In the present study, the signifi-
cant difference in the nocturnal MAP in the 7th year of life
indicates an increased risk of HT and associated complica-
tions in infants with birth weights of < 1000 g. The lack
of nighttime elevation in MAP in the 11th year of life can be
attributed to the success of the HT treatment.
According to the literature, children born prematurely
also show enhanced sympathetic nervous system activity
(26). This phenomenon, in addition to lower myocardial
mass, explains the higher HR occurring in children born
with a low birth weight (25). This relation was confirmed
in the present study, both at the age of 7 and 11 years.
Current guidelines recommend that every child above
the age of 3 years who is seen in a medical setting should
undergo BP monitoring (12, 37). In younger children, the
BP should be measured in cases where there is an increased
risk of HT, including neonatal conditions requiring inten-
sive care, congenital heart disease, renal disease, or treat-
ment with drugs known to raise BP (12, 38). However, re-
cently published studies have shown that these recom-
mendations are rarely applied, either in Europe or the U.S.
(39, 40). This problem may be explained by technical dif-
ficulties associated with correct BP measurement in chil-
dren (appropriate cuff size, difficulties in auscultation)
(19). However, routine BP measurements are necessary, as
HT in children is often asymptomatic or presents as non-
characteristic symptoms, such as headaches, nose bleed-
ing, shortness of breath, changes in behavior, or learning
difficulties (19).
In the present study, all the children were treated ac-
cording to ESH/ESC Guidelines for the management of ar-
terial hypertension (latest update published in 2013) (14).
The necessity of treatment intensification was assessed on
the basis of casual BP measurements. In ABPM performed
after 4 years of HT therapy, few children were still managed
with elevated BP. This finding indicates that recommended
casual BP measurements are an important screening tool,
but these may be insufficient in children at risk of HT. In
such cases, 24-h ABPMs offer a valuable method of pressure
measuring (12). 24-h-long registration allows evaluating
the SBP profile regarding to physical activity and the rest of
the night. It also eliminates so-called white coat hyperten-
sion and masked hypertension, both of which are common
in children. Instead of routine measurements, in preterms
with ELBWs, 24-h ABPM should be considered as an initial
tool to screen for HT.
5.1. Strengths and Limitations
In our opinion, this study has significant value and
provides new insights into HT in 10 - 11-year-olds who had
ELBWs. First, the study group included the majority of new-
borns from the entire Malopolska region who were born
within a 2-year period and reached the age of 11 years. The
data in this multicenter study were obtained from all the
tertiary referral centers in this region. It is a complete
group of patients, with a high percentage of observation.
In addition, the assessment of HT was based on 24-h BP
monitoring.
The limitation of our study is the unequal size of the
study and control groups. Furthermore, the analyses may
be limited in power due to the small sample size of the
groups.
5.2. Conclusions
Children born prematurely are predisposed to HT in
later life. Furthermore, the increase in the HRs of ex-
preterms is maintained in the 7th and 11th years of life,
despite anti-HT treatment. Rapid implementation of HT
treatment in ex-preterm infants can reduce their BP values
to those of the general population. We propose hat 24-hr
ABPM should be considered as an initial screening tool or
in the follow-up of children born prematurely with ELBWs.
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